Evidence map›Paper›PMID 37623224›Full record

ArticleCurrent issues in molecular biology2023

Antidiabetic Effect of Fermented

Hye-Lin Kim, Yunu Jung, Hyo In Kim, Nak-Yun Sung, Min-Jee Kim, In-Jun Han, Geon Kim, Eun Yeong Nho, Sang-Yun Park, Yohan Han and 3 more

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Transcription FactorInternational journal of molecular sciences · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Hye-Lin KimCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.
Yunu JungDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.ORCID 0000-0002-2279-7896
Hyo In KimDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Nak-Yun SungDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.
Min-Jee KimDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.
In-Jun HanDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.ORCID 0000-0001-8706-8363
Geon KimDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.
Eun Yeong NhoDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.
Sang-Yun ParkDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.
Yohan HanCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.
Ji Hoon JungCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.ORCID 0000-0002-5644-5960
Dong-Sub KimDivision of Natural Product Research, Korea Prime Pharmacy Co., Ltd., Suwon 16229, Republic of Korea.ORCID 0000-0002-6843-0360
Jinbong ParkCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.ORCID 0000-0002-5984-5855
Kyung Hee University · KRBeth Israel Deaconess Medical Center · US

Funding

Ministry of Trade, Industry and Energy p0015309
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is a serious health issue with increasing incidences worldwide. However, current medications have limitations due to side effects such as decreased appetite, stomach pain, diarrhea, and extreme tiredness. Here, we report the effect of fermented ice plant (FMC) in the T2M mouse model of

Indexed as

AMP-activated protein kinasefermented ice plantinsulin receptor substrate 1Mesembryanthemum crystallinum L.nuclear factor erythroid 2–related factor 2phosphoinositide 3-kinaseprotein kinase Btype 2 diabetes

Identifiers

PMID37623224
PMCPMC10453056
OpenAlexW4385543433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.